{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:09:39Z","timestamp":1789708179404,"version":"4.0.1"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anticancer Res"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.21873\/anticanres.12697","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:50:12Z","timestamp":1530643812000},"page":"4073-4081","source":"Crossref","is-referenced-by-count":15,"title":["Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer"],"prefix":"10.21873","volume":"38","author":[{"given":"KOICHI","family":"SAKAGUCHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATSUHIKO","family":"NAKATSUKASA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROSHI","family":"KOYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAKOTO","family":"KATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"SAKUYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAYUKI","family":"MATSUDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NOBUYUKI","family":"TSUNODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IKUYA","family":"FUJIWARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAHIDE","family":"YAMAGUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROKI","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUYOSHI","family":"ONISHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIE","family":"ONISHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUJI","family":"YOSHINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"KIKUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUYA","family":"TAGUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"9336","published-online":{"date-parts":[[2018,7,3]]},"container-title":["Anticancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ar.iiarjournals.org\/lookup\/doi\/10.21873\/anticanres.12697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T20:26:44Z","timestamp":1643833604000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/lookup\/doi\/10.21873\/anticanres.12697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,3]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.21873\/anticanres.12697"],"URL":"https:\/\/doi.org\/10.21873\/anticanres.12697","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"value":"0250-7005","type":"print"},{"value":"1791-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}